Antiplatelet therapy after endovascular intervention: Does combination therapy really work and what is the optimum duration of therapy?

Milani, Richard V. (2009). Antiplatelet therapy after endovascular intervention: Does combination therapy really work and what is the optimum duration of therapy?. In: VIVA 06: Meeting on Vascular Interventional Advances, Las Vegas, NV, United States, (S7-S11). 26-29 September 2006. doi:10.1002/ccd.21996


Author Milani, Richard V.
Title of paper Antiplatelet therapy after endovascular intervention: Does combination therapy really work and what is the optimum duration of therapy?
Conference name VIVA 06: Meeting on Vascular Interventional Advances
Conference location Las Vegas, NV, United States
Conference dates 26-29 September 2006
Journal name Catheterization and Cardiovascular Interventions   Check publisher's open access policy
Place of Publication Hoboken, NJ, United States
Publisher John Wiley & Sons
Publication Year 2009
Sub-type Fully published paper
DOI 10.1002/ccd.21996
ISSN 1522-1946
1522-726X
Volume 74
Issue S1
Start page S7
End page S11
Total pages 5
Language eng
Abstract/Summary The number of patients undergoing peripheral interventions has increased in recent years, highlighting the need for a safe and effective protective antithrombotic therapy. Platelet inhibition following coronary intervention is associated with a significantly reduced risk of graft occlusion, and has been acknowledged to be safe and effective in patients with peripheral arterial disease. Monotherapy with either aspirin or clopidogrel, reduces the rate of stroke, myocardial infarction, and cardiovascular death in patients suffering from peripheral arterial disease. Limited data from clinical trials investigating combination therapy of aspirin with ticlopidine or clopidogrel in patients undergoing endovascular interventions, have suggested the potential for a reduction in cardiovascular events. Nevertheless, the optimal duration of postintervention antiplatelet therapy remains to be defined.
Keyword Platelets
Atherothrombosis
Angioplasty
Q-Index Code E1
Q-Index Status Provisional Code
Institutional Status Non-UQ
Additional Notes Supplement: Thrombosis Summit: How To Handle Common Scenarios Without Evidence

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 5 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 7 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Mon, 14 Mar 2011, 19:51:28 EST